Mechanisms and Risk Factors of Cognitive Impairment in COPD

Area of Science:

• Pulmonary Medicine
• Neurology
• Gerontology

Background:

• Cognitive impairment (CI) is an underrecognized complication of Chronic Obstructive Pulmonary Disease (COPD).
• CI in COPD is prevalent and significantly affects disease management, adherence, exacerbations, and quality of life.
• The biological mechanisms underlying CI in COPD are not well-defined.

Purpose of the Study:

• To review the current understanding of the biological mechanisms contributing to cognitive impairment in COPD.
• To highlight the clinical significance and prevalence of CI in COPD.
• To discuss potential therapeutic strategies and the need for COPD-specific cognitive assessments.

Main Methods:

• Literature review of studies investigating mechanisms of cognitive impairment in COPD.
• Analysis of evidence linking COPD-related factors (hypoxemia, sleep-disordered breathing, oxidative stress, vascular dysfunction, hypercapnia) to cognitive decline.
• Synthesis of findings on prevalence, clinical impact, and potential interventions.

Main Results:

• Chronic hypoxemia, sleep-disordered breathing, oxidative stress, vascular dysfunction, and chronic hypercapnia are implicated in CI in COPD.
• These factors contribute through cerebral metabolic dysfunction, structural brain changes, glymphatic dysfunction, inflammation, and endothelial dysfunction.
• Shared risk factors may explain the co-occurrence of vascular dysfunction and CI in COPD patients.

Conclusions:

• CI in COPD may represent distinct biological subtypes, not a uniform comorbidity.
• Current cognitive screening tools may underestimate CI in COPD; validated, COPD-specific assessments are needed.
• Further research is required to test interventions like oxygen therapy and treatments for sleep-disordered breathing, and to develop precision interventions using emerging tools.